Thriving in Psychedelic Therapy: Key Trends and Business Strategies for Success
Embracing the New Horizons of Psychedelic Therapy: Navigating Current Trends and Challenges Psychedelic therapy is experiencing a renaissance, spurred by groundbreaking research and increasing public
Navigating Legal Landscapes in Psychedelic Therapy
The practice of psychedelic therapy is rapidly gaining recognition for its potential benefits in treating various mental health conditions. However, therapists in this field must
THE STATE of the KETAMINE SECTOR
The recent Ketamine Provider Survey, which closed on June 1, 2024, conducted by Advaya Health and Wellness with the support of Psytelligence provides keen insights
Psytelligence “Ask the Experts” Event – Video and Summary
https://www.youtube.com/watch?v=3DNrlmYAofE The landscape of psychedelic therapy is rapidly evolving, presenting unique opportunities and challenges for practitioners. To help navigate this complex field, a recent event
Psychedelic Therapy Finance Expert: Jeffrey Krepps, Co-Founder, Advaya Health and Wellness
Jeffrey Krepps is a seasoned mental health therapist and finance expert with over 20 years of experience in developing healthcare organizations. As Co-Founder and Chief Business
Psychedelic Marketing Expert: Steen Beck, Media Director, Tricycle Day
Steen Beck is the dynamic Media Director at Tricycle Day, a leading platform in the psychedelic industry known for its innovative marketing strategies and engaging
Psytelligence Legal Expert: Natasha Sumner, Senior Counsel, Husch Blackwell Law Firm
Natasha Sumner is a leading authority in the field of psychedelic therapy law, serving as Senior Counsel at Husch Blackwell. She co-leads the firm’s groundbreaking
Psytelligence Presents: “Ask the Experts” Event
Date: June 21st, 2024 Time: 10-11:30amPT / 1-2:30pmET Format: Free Online Panel Discussion Join us for the Psytelligence “Ask the Experts” Event where Psychedelic Therapists
The FDA is Addicted to Drugs
The FDA’s recent review of MDMA-assisted therapy for PTSD has highlighted a critical flaw within the organization: its addiction to drugs. The FDA’s regulatory framework
Ensuring Your Psychedelic Therapy Reaches Those in Need
As a psychedelic therapist, your mission is to provide transformative healing to those suffering from mental health challenges. However, to fulfill this mission, you need
Building a Sustainable Psychedelic Therapy Practice Helps More People
Struggling with finances? Secure your psychedelic therapy practice to open doors for more clients. Financial stability is crucial for any successful practice, and psychedelic therapy
The Critical Role of Intake in Psychedelic Therapy: Ensuring Safety and Efficacy
Psychedelic therapy is emerging as a transformative tool in mental health treatment, promising significant improvements for conditions such as depression, PTSD, and anxiety. However, the
Coming Out Of The Psychedelic Closet with Psytelligence
We want to share a journey that deeply impacts our founder, Eric Shumake. Eric has battled treatment-resistant depression his whole life, a challenge that intensified
The DEA’s Potential Rescheduling of Marijuana (which is definitely a psychedelic)
The U.S. Drug Enforcement Administration (DEA) is reviewing marijuana’s classification under the Controlled Substances Act following a recommendation by Health and Human Services (HHS). HHS
Examining Ketamine Therapy As a Workplace Benefit
Introduction In the rising global mental health epidemic severe challenges, such as depression, anxiety, and post-traumatic stress disorder (PTSD), continue to significantly impact employee well-being
Celebrating Bicycle Day with Tricycle Day: Your Weekly Psychedelic Digest
Today is Bicycle Day and on the anniversary of Albert Hofmann’s pioneering LSD trip, today is also a great time to highlight a key resources
The Aspen Psychedelic Symposium 2024: Where Ancient Wisdom Meets Modern Science
Aspen, Colorado is experiencing something truly incredible as its citizens experience a remarkable revival of one of humanity’s oldest medicines – psychedelics. From May 31st-2024
Porta Sophia: Protecting Public Domain Innovation in Psychedelic Science
Porta Sophia is playing an invaluable role in protecting public domain and ethical advancement in psychedelic research and innovation, especially as the popularity of psychedelic therapies increases, increasing the potential for overly broad patents that could prevent access to potentially lifesaving treatments.
Psychedelics Design: Exploring the Intersection of Consciousness and Creativity
At its core, Psychedelics Design is a platform that investigates the potential of psychedelics through the lens of design. It serves as a space for
Listening To The Healers: Psytelligence Psychedelic Therapist Support Survey Report
Introduction: Psychedelic therapy has transformative potential for healing and personal growth. To gain a deeper understanding of the experiences, challenges, and needs of psychedelic therapists,
Josh Hardman: Pioneering Psychedelic Insights and Community Engagement with Psychedelic Alpha
Josh Hardman is widely respected within the psychedelic industry for his contributions as founder and thought leader behind www.psychedelicalpha.com, an information hub dedicated to providing
MindMed: Revolution in Anxiety Treatment with MM120 for Generalized Anxiety Disorder.
MindMed’s Phase 2b trial of MM120 in GAD achieved its key secondary endpoint, with 12-week topline data showing clinically and statistically significant durability of activity
Discovering Psychedelic Wellness – open:minds EXPO
As mental health and personal well-being concerns have grown increasingly pressing in recent years, the growing awareness of psychedelic wellness as an effective approach to
mychedelica: Revolutionizing psychedelic medicine through medical communication
In the face of a mounting global mental health crisis, mychedelica emerges as a pioneering force in the field of psychiatric support, specializing in expert
The Sage Collective: Reimagining Healthcare Through Purpose-Driven Consulting Services
As healthcare is rapidly transforming, innovation and purpose are of utmost importance. Enter The Sage Collective, a groundbreaking consulting firm with one goal in mind:
Delving into the Mind’s Landscape: The International Society for Research on Psychedelics Conference 2024
The human mind, vast and unexplored, has captivated curiosity for millennia. And now, a wave of scientific exploration is turning its attention to a once-taboo
Psilouette’s Inspiring Support of Psychedelic Wellness
Psilouette stands out in the psychedelic wellness landscape by taking an integrative approach to incorporating psilocybin into mental health and wellbeing routines. Psilouette is especially
Othership: Navigating Emotional Wellness Through Breathwork
Mental and emotional wellness have become hot topic globally, prompting innovative solutions to arise that meet individuals’ complex needs for solace, clarity, and transformation. One
Protecting Psychedelic Science for Public Benefit: The Remarkable Work of Freedom to Operate
Freedom to Operate (FTO) is a non-profit organization that plays an essential role in the realm of psychedelic research and medical development. Their primary mission
Universal Ibogaine’s Promising Approach to Global Addiction Treatment
Universal Ibogaine Inc. (UI) represents an innovative breakthrough in addiction treatment, particularly those affected by opioid use disorders, through their pioneering use of Ibogaine. Derived
Exploring the Consumer Economic Implications of Psychedelic Assisted Therapies
Psychedelic-assisted therapies have experienced an unprecedented surge in popularity over recent years as an innovative treatment option for mental health. A study by Elliot Marseille,
Social Perspectives: Psychedelic Use in Couples Therapy
Overview This report compiles insights from a discussion thread about the use of psychedelics, particularly MDMA, in couples therapy. The conversation reflects a range of
Social Listening Report: Pursuing a Career in Psychedelic-Assisted Therapy
Overview This report compiles insights from a discussion thread focused on obtaining certification and training for becoming a psychedelic-assisted therapist. The conversation includes a variety
Therapist Perspectives: Accessing Psychedelic Substances for Mental Health Treatment
Overview This report compiles insights from a discussion thread focused on how individuals have accessed psychedelic substances for treating mental health issues. A total of
Maria Sabina: Mazatec Mushroom Shaman who Reconciled Ancient Wisdom with Modern Times
Maria Sabina was born in Huautla de Jimenez, Oaxaca, Mexico and immediately immersed herself into the spiritual and healing traditions of her Mazatec heritage from
Digital Platforms Are Revolutionizing Psychedelic Therapy
Mental health treatment is experiencing dramatic change with the increased use of psychedelic therapies. This shift is furthered by digital platforms designed to facilitate access
Psychedelic Therapist Support Resources Survey
Psychedelic therapists are on the front lines of the mental health crisis, but too often needed resources are not available. This all-volunteer public survey of
MAPS PBC is now Lykos Therapeutics
San Jose, Calif. – On January 5, 2024, MAPS Public Benefit Corporation – now Lykos Therapeutics – an industry pioneer in mental healthcare innovation, celebrated
Atai Life Sciences Takes Strategic Leap – Expanding into Short-Duration Psychedelics With Beckley Psytech Investment
Atai Life Sciences is making waves in the psychedelic therapeutics space with their announcement of a major investment into Beckley Psytech, set to accelerate clinical
Enthea: Pioneering Psychedelic Therapy in Workplace Healthcare
Enthea, a pioneering third-party administrator (TPA) of health insurance plans, has positioned itself as a key player in the evolving landscape of mental healthcare in
Akamai Synthesis Design: Navigating New Horizons in Healthcare
Akamai Synthesis Design (ASD) represents a notable presence in the healthcare consulting landscape. Based in Hawaii, the firm extends its services primarily to businesses in
Client Preferences in Discovering Psychedelic Therapies
Our recent Psychedelic Therapy Public Opinion Survey offers key insight into how potential clients would like to learn about psychedelic therapy services. Data compiled from
Flexibility and Cost in Psychedelic Therapy
Our Psychedelic Therapy Public Opinion Survey with responses from 50 representative individuals from the US population sheds light on key considerations clients make when accessing
Qualification Preferences in Psychedelic Therapy
With responses from 50 individuals in the US representative of the general population, the Psychedelic Therapy Public Opinion Survey offers valuable insight into which qualifications
What Killed Matthew Perry?
Matthew Perry’s sudden death and subsequent findings by the Los Angeles County Coroner’s Office has caused much debate in medical circles regarding the possible role
Impact of Matthew Perry’s Death on Public Health Policy
Matthew Perry’s death has shed new light on ketamine’s use and regulation for mental health treatments, specifically severe depression treatment. Though ketamine has recently become
Embracing Transformation: The Journey of Dr. 1Drea Pennington Wasio in Psychedelic Science and Holistic Wellness
Dr. 1Drea Pennington Wasio is a visionary healer and thought leader in integrative wellness, psychedelic therapy, and personal transformation.Her journey has been marked by remarkable
MAPS Submits Historic New Drug Application for MDMA-Assisted Therapy of PTSD
MAPS Public Benefit Corporation (MAPS PBC), in a groundbreaking move for psychedelic-assisted therapy, announced their submission of a New Drug Application (NDA) to the U.S.
Cybin Phase 2, Washington and Oregon Policy, Legal Psychedelics, and Reduced Investment Outlook
Cybin’s Phase 2 Study Results Cybin, a prominent psychedelic biotech company, has revealed significant findings from its Phase 2 study of CYB003, a psilocybin analogue,
Mindbloom, Clearmind Medicine, Psilocybin for Eating Disorders
Mindbloom’s Mastermind Series Launch: Mindbloom, a prominent provider of psychedelic medicine, announced the launch of its Mastermind Series, the first expert-led psychedelic therapy programs aimed
The Rise of “Better U” in the Expanding U.S. Ketamine Clinics Market
As the U.S. grapples with a mounting mental health crisis, innovative treatment methods like ketamine therapy have emerged as beacons of hope. Among the key
Recent US policy developments in psychedelics
Recent policy developments and advances in psychedelic research demonstrate a fundamental change in perception and regulation of these substances in the United States: Massachusetts Ballot
Psychedelic Market Trends from 2023
Recently, we have witnessed remarkable expansion and development within the psychedelic drug market, with several notable trends emerging during 2023: Market Growth: Between 2022-2023, the
US Veteran’s Administration open to exploring psychedelics to treat PTSD
Since recently, an increasing number of military veterans have turned to psychedelic therapy as an unconventional treatment for post-traumatic stress disorder (PTSD). While this unconventional
Exploring “Tripless” Psychedelics for Healing
Is an immersive psychedelic experience itself is required for therapeutic benefits? Or do alternative approaches such as “tripless” psychedelics could offer greater healing potential? Discovering
Members of European Parliament Advocate EU Support Research into Psychedelic Drugs for Treating Mental Health Disorders
Recently, there has been an surge of advocacy surrounding psychedelic therapies as potential breakthroughs for treating mental health disorders. This movement has now spread into
The Future of Wellness: Unveiling the Wonders of Wonderland Conference
The conference known as Wonderland, taking place from November 9th to 11th, is not your typical industry gathering. It’s a visionary melding of minds and
Sam Mandel and Ketamine Clinics of Los Angeles – Revolutionizing Mental Health Treatment
Los Angeles, known for its vibrant culture and forward-thinking initiatives, is also a leader in mental healthcare. Ketamine therapy has emerged as an innovative treatment
The FDA’s Reluctance Toward Ketamine: Ignoring an Opportunity to Address Opioids and Mental Health Crises?
The Food and Drug Administration (FDA) recently released a statement regarding compounded ketamine products used for treating mental disorders. While raising legitimate safety issues associated
Remembering Dr. Roland Griffiths: A Luminary in Psychedelic Spiritual Research
Roland Griffiths was no ordinary scientist. While most of his peers shied away from controversial psychedelic research, he saw potential. Dr. Griffiths recently passed away
Fred Tomaselli’s Psychedelic Artistry: Balancing Reality and Illusion
Contemporary art has produced some extraordinary artists whose works transcend convention, offering viewers a glimpse of something extraordinary. Fred Tomaselli stands out as an artist
Healing Global Trauma: The Potential of Psychedelics in Ending War
In today’s world of conflict and strife, unconventional strategies for ending wars must be pursued with great urgency. This article investigates whether using psychedelics –
Exploring California’s New Era for Psychedelics and Cannabis: Examining Assembly Bill 1021 and 623
Recent developments in California’s drug policy represent a major step in revamping society’s perception and handling of psychoactive substances. Governor Gavin Newsom just signed two
Psychedelics and The Open Mind: Investigating Correlations
Human cognition remains one of the great mysteries in science. A recent research paper in Scientific Reports v 13 entitled “Alternative Beliefs among Psychedelic Drug
Millennials, Psychedelics and Mental Health: A Generational and Cultural Shift
As the mental health conversation has broadened, an unexpected yet notable development has emerged: an interest among millennials to utilize psychedelics for mental health treatment,
Psycheceutical, Inc. – Advancing Mental Health Treatment with Next-Generation Biotech Solutions
Mental health has become a focus of societal attention, given the opioid crisis and increasing prevalence of mental disorders. A myriad of companies are exploring
Integrating Indigenous Ethics Into Psychedelic Studies: A Path towards Reciprocity and Respect
Recent years have witnessed an explosion of interest in psychedelic research and therapy, particularly the therapeutic potential of substances such as psilocybin mushrooms, ayahuasca, and
Blossom: A Model of Interconnected Knowledge in Psychedelic Research
The field of psychedelic research, while not entirely new, is seeing a resurgence in both interest and credibility. As researchers, medical professionals, and the general
Breaking News: A recent MAPS study suggests that MDMA-Assisted therapy may be a promising treatment for post-traumatic stress disorder (PTSD).
An innovative treatment for those grappling with mild to severe PTSD has been introduced. Research backed by the Multidisciplinary Association for Psychedelic Studies (MAPS) indicates
Derek Du Chesne: A Journey to Mental Health Advocacy
From captivating audiences on screen to leading vital shifts in mental health, Derek Du Chesne’s story is a testament to the power of transformation and
Psytelligence Podcast with Kimberly Chew of Husch Blackwell Law
Join us as we chat with Psychedelic Lawyer Kimberly Chew, Senior Counsel, Co-leader of Psychedelics and Emerging Therapies Practice Group at law firm Husch Blackwell
Psychedelic Therapy US Public Opinion Research Report
Introduction: One emerging area of mental health treatments that has generated much discussion and controversy is Psychedelic Therapy. The use of psychedelic substances in therapeutic
A Case for H.R. 3684 – the Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023
Policy Brief by Kris MetzgerSchool of Social Work, Boston University Abstract The purpose of this policy brief is to first examine the alarming mental health
Saint Ketamine: The Beneficial Effects of Ketamine on Mental Health
Saint Ketamine: The Beneficial Effects of Ketamine on Mental Health – offers readers an unforgettable journey into mental health and its intersection with ketamine’s remarkable
California Assembly Approves Bill to Decriminalize Psychotropic Substances
In an unprecedented move, the California State Assembly has given its approval for an innovative bill aimed at decriminalizing certain psychedelic substances. Decriminalizing PsychedelicsSenate Bill
Virtual Reality and Psychedelic Therapy as Revolution in Mental Health Treatment
Mental health treatment is currently undergoing dramatic change as innovative technologies emerge and new approaches come into play. Recently, virtual reality (VR) and psychedelic therapy
Preserving Indigenous Traditions Amidst Rising Psychedelic Use
In recent times, Indigenous communities have raised their voices to safeguard their sacred traditions and ancestral medicinal practices as the use of psychedelics becomes more
MAPS Unveils Online Access to Psychedelic Science 2023 through “PS2023: The Virtual Trip”
MAPS, an innovative non-profit dedicated to research and education surrounding the responsible use of psychedelics and marijuana, has taken significant strides toward making transformative knowledge
Psytelligence General US Public Ketamine Therapy Awareness and Sentiment Report
Section 1: Introduction This report provides a detailed analysis of the factors influencing the choice of mental health treatment providers, with a specific focus on
Cybin Inc: Pioneering A New Age of Mental Healthcare
Cybin Inc, a clinical-stage biopharmaceutical company founded in 2019, is at the forefront of mental healthcare innovation. They are focused on developing novel psychedelic-based treatments.
Bright Side of The Moon: A New Era of Bipartisan Support for Psychedelic Medicine and Policy
At a time of political division, psychedelics is creating an unexpected pathway through Congress by drawing support from both sides of the aisle. From medical
COMPASS Pathways Announces Major Funding Initiative to Advance Psychedelic Medicine Research
Compass Pathways plc (Nasdaq: CMPS), based in London, has announced significant advances in psychedelic medicine involving psilocybin therapy for mental health conditions. They recently secured
Psychedelics for Everyone: An Exploration into Psychedelic Therapy with Matt Zemon
Mental health treatments and medications have greatly advanced, leading to an array of solutions that have greatly increased global mental wellbeing. Yet one potential therapeutic
Marketing and Psychedelics: Moving Beyond Stereotypes
Marketing and psychedelics have each experienced a sometimes unfavorable reputation in our society. Marketing may be seen as using manipulative tactics to create value for
Oregon Completes Psychedelic Mushroom Treatment Framework
Oregon recently made history when they legalized psilocybin mushrooms (commonly known as “psychedelic mushrooms”) for therapeutic use, sparking much discussion and speculation surrounding this new
Psychotropic Therapy Becoming a Popular Workplace Perk
Over the past decade, mental health treatment has undergone dramatic change. Perhaps one of the most remarkable developments has been the rapid adoption of psychedelic
The Benefits of Ketamine for Autism
Ketamine, a powerful anesthetic which induces a trance-like state while offering pain relief, sedation, and amnesia, has recently come under scrutiny as potential treatment for
Embracing PsyTech: A UX-Centric Perspective
In the world of Psychedelic Technology (PsyTech), the confluence of human consciousness and technological advancements has kickstarted a revolution, changing the way we approach therapy
AMA Guidance Recommends FDA Oversight in Psychedelic Therapy: Balancing Innovation with Safety
The American Medical Association’s (AMA) recent guidance encouraging FDA oversight for medicinal psychedelic use could have significant ramifications on this emerging field of therapy. The
Is the Buzz Around Psychedelic Healthcare Fading Fast?
Recently, the healthcare sector was abuzz with excitement over the potential of using psychedelic substances to treat mental health conditions. Tiffany Kary and Bloomberg, writing
Australia Enters into a New Era of Psychedelic Medicine
Advocates around the globe have long touted the therapeutic advantages of psychedelic drugs like MDMA, psilocybin (the active component found in magic mushrooms), and ketamine
USPTO Rejects ATAI Life Sciences’ Ibogaine Co-Administration Patent Application: Implications and Insights
The application for patent 17/941,648 bu ATAI Life Sciences is being disapproved at non-final stage by the United States Patent and Trademark Office (USPTO). Their
Autism and Psychedelics: Exploring A Neurological Crossroads
Psychedelic substances have long been seen as controversial and unexplored areas in medical research, yet in recent years there has been renewed interest in exploring
Heading Health: Shaping the Future of Integrative Psychiatry with Psychedelics
Heading Health stands out in an ever-evolving field of mental health care by adopting an innovative approach. Based in Texas, this leading group combines traditional
Understanding the Economics: Cost Modeling for Ketamine Clinics
The field of psychedelics is experiencing unprecedented growth. The proliferation of ketamine treatment clinics in the United States is a testament to this. These clinics offer
Dark Side of the Moon – How Psychedelics Bring Conservatives and Liberals together
Today’s world is marked by a growing political polarization with sharp divisions between political left and political right. Unexpectedly, a common interest in altered states of
Timothy Ferriss Is a Maverick Promoter in the Therapeutic Psychedelic Revolution
Timothy Ferriss has made a name for himself as an unconventional entrepreneur who embraces unconventional approaches in pursuit of improving human performance. After upending conventional
MindPlace: Visualizing the Future of Psychedelic Technology
PsyTech (Psychedelic Technology), is an emerging field that brings together ancient consciousness exploration practices with modern technological tools and devices designed to accelerate personal growth
Hybrid Clinics: Advancing Remote and In-Person Psychedelic Therapy
As our world continues to adjust to life after a global pandemic, hybrid clinics are making waves in healthcare. These unique healthcare facilities combine traditional
FDA Issues Draft Guidance on Clinical Trials With Psychedelic Drugs
On June 23, 2023, the Food and Drug Administration (FDA) took an important step toward acknowledging the growing interest in psychedelic drugs as potential medical